Exact Sciences: Cancer Detection Stalwart's Bad Quarter Resets Its Overgrown Market Cap.
Exact Sciences may have had disappointing Q3 earnings, but its liquidity cushions and new product approval indicate strong ...
Exact Sciences首席执行官Kevin Conroy购买价值100万美元的股票
威斯康星州麦迪逊市—Exact Sciences Corp (NASDAQ:EXAS)总裁兼首席执行官Kevin Conroy近期大量购入公司普通股。根据最新的SEC文件显示，Conroy于11月13日以每股51.35美元的价格购入19,500股，总投资额为1,001,325美元。 此次交易使Conroy的直接持股增加到1,074,191股。此外，他还通过退休和信托账户间接持有公司股票，以及683 ...
Exact Sciences Corporation (EXAS) Rebounded from the Previous Quarter
Columbia Acorn Fund, distributed by Columbia Management Investment Distributors, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the quarter, the fund ...
Yahoo Finance6 天
Exact Sciences’ forecast cut shocks analysts
Exact Sciences reported third-quarter results that fell short of analyst expectations and cut its guidance for the fourth ...
Exact Sciences报告早期癌症检测取得进展
威斯康星州麦迪逊 - 以癌症筛查和诊断测试而闻名的Exact Sciences Corp. (NASDAQ: EXAS)公布了研究结果，显示多癌症早期检测 (MCED)测试取得进展。在圣地亚哥举行的美国癌症研究协会特别会议上展示的研究表明，一种新的多生物标志物方法可以提高癌症检测率，尤其是在早期阶段。
Exact Sciences: Q3 Sell-Off May Be Unjustified, But Long-Term Outlook A Concern
Exact Sciences' Q3 report led to a ~25% drop in share price, due to a slight guidance cut and narrow revenue miss. Learn more ...
bovnews1 天
Analysts Predict a $75 Target for Exact Sciences Corp (EXAS) Stock—What Could Drive It There?
Wells Fargo has recently initiated Exact Sciences Corp (EXAS) stock to Overweight rating, as announced on August 28, 2024, according to Finviz. Earlier, on June 27, 2024, Scotiabank had initiated the ...
Investor's Business Daily on MSN8 天
Exact Sciences Collapses On 'Alarming' Guidance Cut. Is The Growth Story Broken?
Exact Sciences stock collapsed Wednesday after the Cologuard maker reported light third-quarter sales and cut its full-year ...
Investor's Business Daily on MSN8 天
Exact Sciences Stock Falls 29% On Weak Results, Downbeat Outlook
Exact Sciences stock tumbled late Tuesday after the company cut its outlook and posted weaker-than-expected results.Shares of ...
bovnews3 天
Exact Sciences Corp (EXAS) Shock: Unpacking Today’s Price Drop
On Friday, Exact Sciences Corp (EXAS) stock saw a decline, ending the day at $51.48 which represents a decrease of $-1.75 or -3.29% from the prior close of $53.23. The stock opened at $53.14 and ...